TRINETRA › Sectors › Healthcare
Rainbow Childrens Medicare Limited (RAINBOW) — share price, P/E and fundamentals
Rainbow Childrens Medicare Limited (NSE: RAINBOW) closed at ₹1,218.70 on 30 Oct 2026, -9.6% over one year, against a 52-week range of ₹1,084.00 – ₹1,610.00.
In the quarter ended 30 Sept 2026 (consolidated, filed 31 Oct 2026) it reported revenue of ₹548 cr and net profit of ₹82 cr, a 15.0% net margin; revenue grew 23.2% and profit grew 8.9% year on year.
On four consecutive filed quarters its trailing P/E is 42.4; since 26 May 2025 its own P/E has ranged from 42.6 to 67.7 (median 55.3), and today's reading is higher than 5% of those 354 trading days.
From the balance sheet dated 30 Sept 2026: return on equity 19.2%, ROCE 19.5%, debt-to-equity 0.00, Piotroski F-score 7 of 9.
Against 65 Healthcare peers on NSE: Net margin higher than 57% of 63 sector peers; PBT margin higher than 56% of 63 sector peers; ROE higher than 71% of 63 sector peers.
Key figures
| Last close | ₹1,218.70 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -13.7% / -1.9% / -9.6% |
| 52-week low – high | ₹1,084.00 – ₹1,610.00 |
| Market capitalisation | ₹12,378 cr |
| Trailing P/E | 42.4 |
| Price / book | 7.22 |
| EV / EBITDA | 19.6 |
| Earnings yield | 2.4% |
| TTM EPS | ₹28.77 |
| TTM net profit | ₹292 cr |
| Quarter revenue | ₹548 cr |
| Quarter net profit | ₹82 cr |
| Net margin | 15.0% |
| Revenue growth (YoY) | +23.2% |
| Profit growth (YoY) | +8.9% |
| Return on equity | 19.2% |
| ROCE | 19.5% |
| Debt / equity | 0.00 |
| Current ratio | 3.51 |
| Free cash flow | ₹80 cr |
| Piotroski F-score | 7 / 9 |
| Average daily turnover (50 days) | ₹13.9 cr |
Against Healthcare peers
| Metric | RAINBOW | Peer median | Percentile |
|---|---|---|---|
| Net margin | 14.98 | 12.67 | 57 |
| PBT margin | 20.35 | 17.57 | 56 |
| ROE | 19.16 | 13.86 | 71 |
| ROCE | 19.49 | 17.26 | 64 |
| Debt / equity | 0.00 | 0.11 | 12 |
| FCF margin | 7.82 | -0.87 | 60 |
| Cash conversion | 1.49 | 1.25 | 71 |
| Trailing P/E | 42.36 | 43.26 | 44 |
Questions
What is the P/E ratio of Rainbow Childrens Medicare Limited?
Rainbow Childrens Medicare Limited's trailing P/E is 42.4, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 26 May 2025 its P/E has ranged 42.6–67.7.
What were Rainbow Childrens Medicare Limited's latest quarterly results?
For the quarter ended 30 Sept 2026, Rainbow Childrens Medicare Limited reported revenue of ₹548 cr and net profit of ₹82 cr (consolidated), filed with the exchange on 31 Oct 2026.
What is Rainbow Childrens Medicare Limited's ROE?
Return on equity is 19.2% based on the balance sheet dated 30 Sept 2026.
Does Rainbow Childrens Medicare Limited have debt?
Debt-to-equity is 0.00 on the balance sheet dated 30 Sept 2026.
What is RAINBOW's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, RAINBOW traded between ₹1,084.00 and ₹1,610.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Sept 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.